Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Metabolic rearrangements in primary liver cancers: cause and consequences
Letizia Satriano, Monika Lewińska, Pedro M. Rodrigues, et al.
Nature Reviews Gastroenterology & Hepatology (2019) Vol. 16, Iss. 12, pp. 748-766
Closed Access | Times Cited: 196

Showing 26-50 of 196 citing articles:

Glutamine metabolic competition drives immunosuppressive reprogramming of intratumour GPR109A+myeloid cells to promote liver cancer progression
Yang Yang, Tianduo Pei, Chaobao Liu, et al.
Gut (2024), pp. gutjnl-332429
Closed Access | Times Cited: 10
Multiscale Structured Trimetal Oxide Heterojunctions for Urinary Metabolic Phenotype‐Dependent Screening of Early and Small Hepatocellular Carcinoma
Fangying Shi, Liuxin Ning, Nianrong Sun, et al.
Small Methods (2024)
Closed Access | Times Cited: 8
Metabolic perturbations prior to hepatocellular carcinoma diagnosis: Findings from a prospective observational cohort study
Magdalena Stępień, Pekka Keski‐Rahkonen, Agnèta Kiss, et al.
International Journal of Cancer (2020) Vol. 148, Iss. 3, pp. 609-625
Open Access | Times Cited: 61
Glycometabolic rearrangements--aerobic glycolysis in pancreatic cancer: causes, characteristics and clinical applications
Lidong Cao, Jiacheng Wu, Xianzhi Qu, et al.
Journal of Experimental & Clinical Cancer Research (2020) Vol. 39, Iss. 1
Open Access | Times Cited: 59
Metabolic alterations and vulnerabilities in hepatocellular carcinoma
Daniel G. Tenen, Li Chai, Justin L. Tan
Gastroenterology report (2020) Vol. 9, Iss. 1, pp. 1-13
Open Access | Times Cited: 52
CPSF6 links alternative polyadenylation to metabolism adaption in hepatocellular carcinoma progression
Sheng Tan, Ming Zhang, Xinglong Shi, et al.
Journal of Experimental & Clinical Cancer Research (2021) Vol. 40, Iss. 1
Open Access | Times Cited: 47
CRIP1 suppresses BBOX1‐mediated carnitine metabolism to promote stemness in hepatocellular carcinoma
Jing Wang, Yan Zhou, Donghui Zhang, et al.
The EMBO Journal (2022) Vol. 41, Iss. 15
Open Access | Times Cited: 35
The NQO1/p53/SREBP1 axis promotes hepatocellular carcinoma progression and metastasis by regulating Snail stability
Xinyue Wang, Ying Liu, Anna Han, et al.
Oncogene (2022) Vol. 41, Iss. 47, pp. 5107-5120
Closed Access | Times Cited: 35
Untargeted plasma metabolomics for risk prediction of hepatocellular carcinoma: A prospective study in two Chinese cohorts
Dong Hang, Xiaolin Yang, Jiayi Lu, et al.
International Journal of Cancer (2022) Vol. 151, Iss. 12, pp. 2144-2154
Closed Access | Times Cited: 29
Cholangiocarcinoma progression depends on the uptake and metabolization of extracellular lipids
Mikel Ruiz de Gauna, Francesca Biancaniello, Francisco González‐Romero, et al.
Hepatology (2022) Vol. 76, Iss. 6, pp. 1617-1633
Open Access | Times Cited: 28
Decreased propionyl-CoA metabolism facilitates metabolic reprogramming and promotes hepatocellular carcinoma
Jiaqi Sun, Jun Ding, Qingsong Shen, et al.
Journal of Hepatology (2022) Vol. 78, Iss. 3, pp. 627-642
Closed Access | Times Cited: 28
miR‐21‐5p promotes NASH‐related hepatocarcinogenesis
Pedro M. Rodrigues, Marta B. Afonso, André L. Simão, et al.
Liver International (2023) Vol. 43, Iss. 10, pp. 2256-2274
Open Access | Times Cited: 18
SIRT1 activation promotes energy homeostasis and reprograms liver cancer metabolism
Benluvankar Varghese, Ugo Chianese, Lucia Capasso, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 17
Hepatocellular carcinoma biomarkers screening based on hydrogel photonic barcodes with tyramine deposition amplified ELISA
Wenjing Xue, Li Wang, Kexin Yi, et al.
Biosensors and Bioelectronics (2024) Vol. 255, pp. 116270-116270
Closed Access | Times Cited: 7
Lifestyle factors, glycemic traits, and lipoprotein traits and risk of liver cancer: a Mendelian randomization analysis
Honglu Zhang, Jiyong Liu
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 5
Development and validation of a CTNNB1‐associated metabolic prognostic model for hepatocellular carcinoma
Junyu Huo, Liqun Wu, Yunjin Zang
Journal of Cellular and Molecular Medicine (2020) Vol. 25, Iss. 2, pp. 1151-1165
Open Access | Times Cited: 46
Redox tolerance and metabolic reprogramming in solid tumors
Keywan Mortezaee
Cell Biology International (2020) Vol. 45, Iss. 2, pp. 273-286
Closed Access | Times Cited: 44
FOSL1 promotes cholangiocarcinoma via transcriptional effectors that could be therapeutically targeted
Adrián Vallejo, Oihane Erice, Rodrigo Entrialgo‐Cadierno, et al.
Journal of Hepatology (2021) Vol. 75, Iss. 2, pp. 363-376
Open Access | Times Cited: 39
Augmented Reality Navigation for Stereoscopic Laparoscopic Anatomical Hepatectomy of Primary Liver Cancer: Preliminary Experience
Weiqi Zhang, Wen Zhu, Jian Yang, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 33
Targeting cancer-specific metabolic pathways for developing novel cancer therapeutics
Soumik Pal, Amit Sharma, Sam Padalumavunkal Mathew, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 27
Serum Metabolomic Profiling Reveals Biomarkers for Early Detection and Prognosis of Esophageal Squamous Cell Carcinoma
Pan Pan Wang, Xin Song, Xue Ke Zhao, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 23
Trends in Incidence and Prognostic Factors of Two Subtypes of Primary Liver Cancers: A Surveillance, Epidemiology, and End Results-Based Population Study
Jiping Yao, Xue Liang, Yanning Liu, et al.
Cancer Control (2022) Vol. 29
Open Access | Times Cited: 22
Liver Organoids as an In Vitro Model to Study Primary Liver Cancer
Silvia De Siervi, Cristian Turato
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 5, pp. 4529-4529
Open Access | Times Cited: 15
The contradictory roles of macrophages in non-alcoholic fatty liver disease and primary liver cancer—Challenges and opportunities
Marlene Kohlhepp, Hanyang Liu, Frank Tacke, et al.
Frontiers in Molecular Biosciences (2023) Vol. 10
Open Access | Times Cited: 14
MYC in liver cancer: mechanisms and targeted therapy opportunities
Furong Liu, Zhibin Liao, Zhanguo Zhang
Oncogene (2023) Vol. 42, Iss. 45, pp. 3303-3318
Closed Access | Times Cited: 14

Scroll to top